Gordon J. Freeman

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Method of assessing the efficacy of a test agent for modulating pro...
- Patent number 12,258,409
- Issue date Mar 25, 2025
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...
- Patent number 12,186,278
- Issue date Jan 7, 2025
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for upregulating immune responses using combinations of ant...
- Patent number 12,139,535
- Issue date Nov 12, 2024
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof
- Patent number 12,103,972
- Issue date Oct 1, 2024
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- G01 - MEASURING TESTING
Information Patent Grant
Antibody molecules to PD-1 and uses thereof
- Patent number 11,827,704
- Issue date Nov 28, 2023
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for identification, assessment, prevention...
- Patent number 11,584,788
- Issue date Feb 21, 2023
- Dana-Farber Cancer Institute, Inc.
- F. Stephen Hodi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal anti...
- Patent number 11,492,403
- Issue date Nov 8, 2022
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents that modulate RGMb-neogenin-BMP signaling and methods of use...
- Patent number 11,485,787
- Issue date Nov 1, 2022
- Dana-Farber Cancer Institute, Inc.
- Rosemarie Dekruyff
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...
- Patent number 11,413,340
- Issue date Aug 16, 2022
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents that modulate immune cell activation and methods of use thereof
- Patent number 11,359,020
- Issue date Jun 14, 2022
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- G01 - MEASURING TESTING
Information Patent Grant
Methods and compositions for the treatment of persistent infections...
- Patent number 11,359,013
- Issue date Jun 14, 2022
- Emory University
- Gordon Freeman
- G01 - MEASURING TESTING
Information Patent Grant
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor
- Patent number 11,261,251
- Issue date Mar 1, 2022
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for upregulating immune responses using combinations of ant...
- Patent number 11,220,545
- Issue date Jan 11, 2022
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatory T cell PD-1 modulation for regulating T cell effector im...
- Patent number 11,207,393
- Issue date Dec 28, 2021
- President and Fellows of Harvard College
- Arlene H. Sharpe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of detecting TIM-3 using antibody molecules to TIM-3
- Patent number 11,155,620
- Issue date Oct 26, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 F...
- Patent number 11,124,569
- Issue date Sep 21, 2021
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for inhibiting viral entry
- Patent number 11,116,818
- Issue date Sep 14, 2021
- Children's Medical Center Corporation Dana-Farber Cancer Institute
- Hyeryun Choe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,981,990
- Issue date Apr 20, 2021
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Grant
Methods for treating PTEN deficient epithelial cancers using a comb...
- Patent number 10,960,008
- Issue date Mar 30, 2021
- Dana-Farber Cancer Institute, Inc.
- Jean Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in...
- Patent number 10,948,492
- Issue date Mar 16, 2021
- Dana-Farber Cancer Institute, Inc.
- Adam Bass
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single agent anti-PD-L1 and PD-L2 dual binding antibodies and metho...
- Patent number 10,934,353
- Issue date Mar 2, 2021
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- G01 - MEASURING TESTING
Information Patent Grant
NKG2D-fc for immunotherapy
- Patent number 10,865,233
- Issue date Dec 15, 2020
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody molecules to PD-L1 and methods of treating cancer
- Patent number 10,851,165
- Issue date Dec 1, 2020
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to PD-1 and uses thereof
- Patent number 10,752,687
- Issue date Aug 25, 2020
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules to TIM-3 and uses thereof
- Patent number 10,472,419
- Issue date Nov 12, 2019
- Novartis AG
- Catherine Anne Sabatos-Peyton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents that modulate immune cell activation and methods of use thereof
- Patent number 10,457,733
- Issue date Oct 29, 2019
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor
- Patent number 10,370,448
- Issue date Aug 6, 2019
- Emory University
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for the treatment of persistent infections...
- Patent number 10,370,446
- Issue date Aug 6, 2019
- Emory University
- Gordon Freeman
- G01 - MEASURING TESTING
Information Patent Grant
Anti-PD-L1 monoclonal antibodies and fragments thereof
- Patent number 10,202,454
- Issue date Feb 12, 2019
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- G01 - MEASURING TESTING
Information Patent Grant
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor
- Patent number 10,011,656
- Issue date Jul 3, 2018
- Emory University
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF
- Publication number 20250108115
- Publication date Apr 3, 2025
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- G01 - MEASURING TESTING
Information Patent Application
NKG2D-FC FOR IMMUNOTHERAPY
- Publication number 20250092114
- Publication date Mar 20, 2025
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20250066479
- Publication date Feb 27, 2025
- Novartis AG
- Gordon James Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...
- Publication number 20240343808
- Publication date Oct 17, 2024
- Novartis AG
- Gordon James Freeman
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF TREATING AN INDIVIDUAL THAT HAS FAILED AN ANTI-PD-1/ANTI...
- Publication number 20230340124
- Publication date Oct 26, 2023
- President and Fellows of Harvard College
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PHOSPHOTYROSINYLATED PROGRAMMED DEATH 1 (PD-1) MONOCLONAL ANTI...
- Publication number 20230331847
- Publication date Oct 19, 2023
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF CORONAVIRU...
- Publication number 20230272359
- Publication date Aug 31, 2023
- DANA-FARBER CANCER INSTITUTE, INC.
- James Torchia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLS
- Publication number 20230203157
- Publication date Jun 29, 2023
- Dana-Farber Cancer Institute, Inc.
- James Torchia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1
- Publication number 20230013364
- Publication date Jan 19, 2023
- Novartis AG
- Glenn Dranoff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...
- Publication number 20230000964
- Publication date Jan 5, 2023
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-CX3CR1 AND I...
- Publication number 20220289854
- Publication date Sep 15, 2022
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220185883
- Publication date Jun 16, 2022
- Novartis AG
- Catherine Anne Sabatos-Peyton
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
- Publication number 20220133889
- Publication date May 5, 2022
- Novartis AG
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING LIVER PD-1-EXPRESSING CD8+ T CELLS USING PD-1 F...
- Publication number 20220041726
- Publication date Feb 10, 2022
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR UPREGULATING IMMUNE RESPONSES USING COMBINATIONS OF ANT...
- Publication number 20220033502
- Publication date Feb 3, 2022
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NKG2D-FC FOR IMMUNOTHERAPY
- Publication number 20220002382
- Publication date Jan 6, 2022
- Dana-Farber Cancer Institute, Inc.
- Glenn Dranoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF
- Publication number 20210284737
- Publication date Sep 16, 2021
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING PTEN DEFICIENT EPITHELIAL CANCERS USING A COMB...
- Publication number 20210267991
- Publication date Sep 2, 2021
- Dana-Farber Cancer Institute, Inc.
- Jean Zhao
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF
- Publication number 20210115144
- Publication date Apr 22, 2021
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-BTNL2 AND IM...
- Publication number 20210032334
- Publication date Feb 4, 2021
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20200339689
- Publication date Oct 29, 2020
- Novartis AG
- Gordon James Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200308277
- Publication date Oct 1, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
- Publication number 20200223926
- Publication date Jul 16, 2020
- Emory University
- Rafi Ahmed
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
- Publication number 20200223917
- Publication date Jul 16, 2020
- Novartis AG
- Catherine Anne Sabatos-Peyton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-PD-1, PD-L1, AND PD-L2 ANTIBODIES AND USES THEREFOR
- Publication number 20200172616
- Publication date Jun 4, 2020
- Dana-Farber Cancer Institute, Inc.
- Gordon J. FREEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PHOSPHOTYROSINYLATED PD-1 ANTIBODIES AND USES THEREOF
- Publication number 20200115452
- Publication date Apr 16, 2020
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGENTS THAT MODULATE IMMUNE CELL ACTIVATION AND METHODS OF USE THEREOF
- Publication number 20200095325
- Publication date Mar 26, 2020
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION...
- Publication number 20190375818
- Publication date Dec 12, 2019
- Dana-Farber Cancer Institute, Inc.
- F. Stephen Hodi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-L1 MONOCLONAL ANTIBODIES AND FRAGMENTS THEREOF
- Publication number 20190330350
- Publication date Oct 31, 2019
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR THE TREATMENT OF PERSISTENT INFECTIONS...
- Publication number 20190309065
- Publication date Oct 10, 2019
- Emory University
- Gordon Freeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Gordon J. Freeman

Person

Patents Grantslast 30 patents

Method of assessing the efficacy of a test agent for modulating pro...

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...

Methods for upregulating immune responses using combinations of ant...

KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof

Antibody molecules to PD-1 and uses thereof

Compositions and methods for identification, assessment, prevention...

Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal anti...

Agents that modulate RGMb-neogenin-BMP signaling and methods of use...

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...

Agents that modulate immune cell activation and methods of use thereof

Methods and compositions for the treatment of persistent infections...

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Methods for upregulating immune responses using combinations of ant...

Regulatory T cell PD-1 modulation for regulating T cell effector im...

Method of detecting TIM-3 using antibody molecules to TIM-3

Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 F...

Compositions and methods for inhibiting viral entry

Antibody molecules to TIM-3 and uses thereof

Methods for treating PTEN deficient epithelial cancers using a comb...

PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in...

Single agent anti-PD-L1 and PD-L2 dual binding antibodies and metho...

NKG2D-fc for immunotherapy

Antibody molecules to PD-L1 and methods of treating cancer

Antibody molecules to PD-1 and uses thereof

Antibody molecules to TIM-3 and uses thereof

Agents that modulate immune cell activation and methods of use thereof

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Methods and compositions for the treatment of persistent infections...

Anti-PD-L1 monoclonal antibodies and fragments thereof

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Patents Applicationslast 30 patents

KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF

NKG2D-FC FOR IMMUNOTHERAPY

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...

METHODS OF TREATING AN INDIVIDUAL THAT HAS FAILED AN ANTI-PD-1/ANTI...

ANTI-PHOSPHOTYROSINYLATED PROGRAMMED DEATH 1 (PD-1) MONOCLONAL ANTI...

METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF CORONAVIRU...

BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLS

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1

MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...

METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-CX3CR1 AND I...

METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

METHODS OF REDUCING LIVER PD-1-EXPRESSING CD8+ T CELLS USING PD-1 F...

METHODS FOR UPREGULATING IMMUNE RESPONSES USING COMBINATIONS OF ANT...

NKG2D-FC FOR IMMUNOTHERAPY

ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF

METHODS FOR TREATING PTEN DEFICIENT EPITHELIAL CANCERS USING A COMB...

KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF

METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-BTNL2 AND IM...

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

HUMAN ANTI-PD-1, PD-L1, AND PD-L2 ANTIBODIES AND USES THEREFOR

ANTI-PHOSPHOTYROSINYLATED PD-1 ANTIBODIES AND USES THEREOF

AGENTS THAT MODULATE IMMUNE CELL ACTIVATION AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION...

ANTI-PD-L1 MONOCLONAL ANTIBODIES AND FRAGMENTS THEREOF

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PERSISTENT INFECTIONS...